2021-02-20 00:53:23 | Why Canada’s Vaccine Rollout Slowed Down

[ad_1]

Story by: Ian Austen The New York Times World News

The large batches of Pfizer vaccines that landed in Canada this week from a plant in Belgium may represent a turning point in the country’s vaccination roll out, even as winter storms delayed the shipments’ arrival.

[Read: France Stalls Between Stubbornly High Infection Rates and Slow Vaccine Rollout]

[Read: Vaccine Shortages Hit E.U. in a Setback for Its Immunization Race]

For my article about Canada, published on Thursday, I spoke with people in a variety of fields including vaccine development, epidemiology, infection control and medical supply chains. All of them said they understood Canadians’ frustration. But none of them were the least bit surprised that the first wave of vaccine deliveries didn’t happen as planned. That, they said, is the nature of new vaccines.

They also cited two factors in the slow start: the lack of an established vaccine maker headquartered in Canada and the country’s modest vaccine manufacturing capability. But they said there was little the government could have done to get such plants up and running by now.

See also  2021-02-09 16:11:34 | Kirill Serebrennikov Is Fired as Director of Gogol Center

Until last summer, Mr. Trudeau and other members of his cabinet repeatedly suggested that they were working to have vaccines coming out of Canadian factories by the end of 2020. But in testimony this week at Parliamentary committee, Mark Lievonen, the vice chairman of the federal vaccine task force, said that there was never a Canadian manufacturing option that could have sped up deliveries. And in earlier testimony, Anita Anand, the minister whose department made the vaccine deals, said that the government was unable last year to persuade any of the major vaccine makers to set up shop in Canada.

There will be domestically made vaccines, but that won’t happen until well after September, the government’s target for getting all Canadians vaccinated. Federally funded plants in Montreal and Saskatoon expect to be operating by the end of the year, which is also the projected delivery date for what would be Canada’s first homegrown vaccine. Its developer, Providence Therapeutics, a biotech start-up based in Calgary, is in early phases of testing the vaccine and has signed a deal to produce those end-of-year batches for Manitoba, assuming regulatory authorization.

Canada may also need less vaccine than first thought. Four studies now suggest that people already infected with the coronavirus need only a single shot of the otherwise two-dose Pfizer and Moderna vaccines for immunity.

What now remains to be seen is if Pfizer and Moderna are able to continue scaling up production and how many of the five other companies Canada placed orders with get their vaccines to market.

See also  2020-10-23 10:18:10 | Portuguese Grand Prix 2020 practice: live updates from Algarve

After reading Dan Bilefsky’s Canada Letter last week about travel restrictions between Canada and the United States, a number of you wrote and asked why people who have been vaccinated aren’t allowed to cross the border into Canada again or be exempted from Canada’s quarantine measures.

False documentation is already an issue with the Covid-19 test results that passengers are required to show before boarding flights. On Thursday, Transport Canada said that it had fined one person 10,000 Canadian dollars and another person 7,000 dollars for boarding a flight to Canada from Mexico last month after they had tested positive. The couple, who have not been named, presented a bogus test result indicting that they were free of infection.

See also  2021-02-20 04:20:35 | Myanmar’s minorities join protest in show of unity against coup | Military News

[ad_2]

Story continues…

Source References: The New York Times World News

Leave a Reply